Next Issue
Volume 11, 04
Previous Issue
Volume 11, 02
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 11, Issue 3 (03 2008) – 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
3 pages, 169 KB  
Editorial
Viagra® für alle?
by Johannes Jehle and Jens P. Hellermann
Cardiovasc. Med. 2008, 11(3), 99; https://doi.org/10.4414/cvm.2008.01311 - 20 Mar 2008
Viewed by 63
Abstract
Hintergrund Mehr als zwei Drittel der Patienten mit chronischer linksventrikulärer systolischer Herzinsuffizienz entwickeln eine pulmonale Hypertonie [...] Full article
2 pages, 320 KB  
Interesting Images
Mechanism of Sudden Cardiac Death in Coronary Artery Disease
by Beat Schaer and Michael Christ
Cardiovasc. Med. 2008, 11(3), 97; https://doi.org/10.4414/cvm.2008.01317 - 20 Mar 2008
Cited by 1 | Viewed by 75
Abstract
An 87-year-old lady with hypertension being her only cardiovascular risk factor was investigated for dyspnoea and chest oppression three years ago, and acute coronary syndrome could be excluded [...] Full article
Show Figures

Figure 1

2 pages, 283 KB  
Interesting Images
Business as Usual?
by J. Fuhrer
Cardiovasc. Med. 2008, 11(3), 95; https://doi.org/10.4414/cvm.2008.01318 - 20 Mar 2008
Viewed by 59
Abstract
Der 61jährige Mann, bei dem keinerlei Kreislaufkrankheiten bekannt waren, hatte anlässlich von Blutdruckselbstmessungen leicht erhöhte Werte und einen Puls von 120 Schlägen pro Minute festgestellt [...] Full article
Show Figures

Figure 1

5 pages, 222 KB  
Editorial
Le Traitement Chirurgical Moderne de la Fibrillation Auriculaire
by Patrick Ruchat, Karam Eisa, Ludwig K. von Segesser and Jürg Schläpfer
Cardiovasc. Med. 2008, 11(3), 90; https://doi.org/10.4414/cvm.2008.01316 - 20 Mar 2008
Viewed by 54
Abstract
Atrial fibrillation (AF) remains the most common sustained arrhythmia disorder, with recurrent symptoms and thromboembolic risk. In the last few years AF has become the focus of intense clinical and experimental interest which confirm that this arrhythmia is due to increased atrial tissue [...] Read more.
Atrial fibrillation (AF) remains the most common sustained arrhythmia disorder, with recurrent symptoms and thromboembolic risk. In the last few years AF has become the focus of intense clinical and experimental interest which confirm that this arrhythmia is due to increased atrial tissue automaticity with subsequent re-entry mechanisms. With better understanding of its pathophysiology, an efficient surgical treatment has been developped. Surgical interventions of supraventicular tachycardias are targeted to neutralise the arrhythmogenic disorder using exclusion or ablation. Several methods can be used like surgical incisions, cryoablation, radiofrequency, microwave or laser energy ablation. Since surgery is a transparietal approach requiring cardiopulmonary bypass, myocardial preservation and atriotomy, associated morbidity is due to the high technicalities of this treatment and not necessarily to the therapy in itself. New developpments in the surgical approach tend to avoid cardiopulmonary bypass to reduce morbidity. The modified Maze procedure with alternative energy sources to achieve transmural atrial lesions allows to broaden surgical indication to all cardiac surgery patients with a history of paroxysmal or permanent AF. The aim of this review is to describe this evolving domain of modern surgical management of atrial fibrillation. Full article
Show Figures

Figure 1

7 pages, 501 KB  
Review
Wertigkeit des EKG im Jahre 2007: Infarkt & Co.
by Richard Kobza, Peiman Jamshidi and Paul Erne
Cardiovasc. Med. 2008, 11(3), 83; https://doi.org/10.4414/cvm.2008.01314 - 20 Mar 2008
Viewed by 73
Abstract
The standard 12-lead electrocardiogram (ECG) remains the most used tool for the diagnosis, early risk stratification, triage, and guidance of therapy in patients with acute coronary syndromes. In general, patients with ST-elevation-infarction and ST-elevation in a large number of leads or high absolute [...] Read more.
The standard 12-lead electrocardiogram (ECG) remains the most used tool for the diagnosis, early risk stratification, triage, and guidance of therapy in patients with acute coronary syndromes. In general, patients with ST-elevation-infarction and ST-elevation in a large number of leads or high absolute sum of ST deviation have a larger myocardial infarction than patients with ST deviation in a smaller number of leads or low sum of ST deviation. ST elevation with negative T waves occurring more than 2 hours of onset of symptoms may be used as a sign of a more advanced stage of infarction or presence of irreversible damage. The admission ECG may assist in identifying the exact site of coronary artery occlusion; this article presents the following relevant ECG patterns: very proximal LAD occlusion in anterior STEMI, left main coronary artery disease and right ventricular infarction accompanying acute inferior STEMI. In patients with unstable angina/non-ST segment elevation myocardial infarction ischaemic burden (quantitative measurements of ST-T-segment deviations) on the admission ECG identifies patients who benefit the most from an invasive treatment strategy. Isolated T-wave inversion identifies a subgroup of patients with unstable angina/non-ST segment elevation myocardial infarction who have a favourable long-term outcome if revascularised very early. Full article
6 pages, 185 KB  
Review
Prevention of Atrial Fibrillation After Surgery
by Robert Blank, Christian Sticherling, Beat Schaer and Stefan Osswald
Cardiovasc. Med. 2008, 11(3), 77; https://doi.org/10.4414/cvm.2008.01313 - 20 Mar 2008
Viewed by 67
Abstract
Postoperative atrial fibrillation (AF) is the most common arrhythmic complication after cardiac surgery. Despite more than 100 trials dealing with the prevention of postoperative AF and improvements in surgical techniques, questions remain about the optimal approach to prevent postoperative AF. Postoperative AF is [...] Read more.
Postoperative atrial fibrillation (AF) is the most common arrhythmic complication after cardiac surgery. Despite more than 100 trials dealing with the prevention of postoperative AF and improvements in surgical techniques, questions remain about the optimal approach to prevent postoperative AF. Postoperative AF is associated with increased morbidity, length of hospital stay and costs, and should, therefore, be avoided. Aim of this article is to give an overview of current trends in the prevention of postoperative AF. Full article
1 pages, 175 KB  
Communication
Jahresbericht 2006 der Arbeitsgruppe «Herzschrittmacher und Elektrophysiologie»
by J. Fuhrer, S. Osswald, U. Bauersfeld, I. Babotai, H. O. Gloor, J. L. Crevoisier, J. Schläpfer and J. Sztajzel
Cardiovasc. Med. 2008, 11(3), 110; https://doi.org/10.4414/cvm.2008.01312 (registering DOI) - 20 Mar 2008
Viewed by 58
Abstract
Im vergangenen Jahr galt die Hauptarbeit des Vorstands erneut dem Thema Qualitätssicherung sowie der Fortbildung unserer zurzeit 171 Arbeitsgruppenmitglieder [...] Full article
1 pages, 171 KB  
Communication
Jahresbericht 2006 der Arbeitsgruppe Lipide und Atherosklerose (AGLA)
by Rubino Mordasini, G. Noseda, R. James, W. Riesen, E. Battegay and R. Darioli
Cardiovasc. Med. 2008, 11(3), 109; https://doi.org/10.4414/cvm.2008.01315 - 20 Mar 2008
Viewed by 56
Abstract
2006 war die AGLAerneut an zahlreichen Veranstaltungen aktiv: Das jährliche Lipidologen- Meeting in Lugano im Frühjahr 2006 war ebenso erfolgreich wie das IX [...] Full article
2 pages, 268 KB  
Communication
Herzpreis für Lausanner Hypertonieforscher
by Thomas F. Lüscher
Cardiovasc. Med. 2008, 11(3), 107; https://doi.org/10.4414/cvm.2008.01319 - 20 Mar 2008
Viewed by 57
Abstract
Die Forscher des Centre Hospitalier Universitaire Vaudois aus Lausanne, Prof. Michel Burnier und Dr. Murielle Bochud (Abb. 1) erhalten für ihre Arbeiten zu genetischen Ursachen des Bluthochdrucks den mit CHF 100 000 dotierten «Sanofi-aventis Heart Prize 2007» [...] Full article
Show Figures

Figure 1

5 pages, 498 KB  
Communication
4. «Cardiovascular Roundtable»
by Ruth Amstein, Frank Enseleit and Thomas F. Lüscher
Cardiovasc. Med. 2008, 11(3), 102; https://doi.org/10.4414/cvm.2008.01310 - 20 Mar 2008
Viewed by 63
Abstract
Hintergrund CARTA, der «Cardiovascular Roundtable» zwischen führenden Vertretern der kardiovaskulären Medizin, der Pharma- und Medizinaltechnikindustrie sowie der Gesundheits- und Bildungspolitik [...] Full article
Previous Issue
Next Issue
Back to TopTop